report
hospitalis
rate
acut
lower
respiratori
infect
alri
includ
pneumonia
indigen
australian
children
remot
area
compar
region
higher
children
develop
countri
despit
burden
date
one
studi
examin
upper
airway
virus
bacteria
indigen
australian
children
remot
commun
hospitalis
alri
studi
conduct
prior
avail
molecular
diagnost
method
studi
use
world
health
organ
clinic
diagnost
criteria
togeth
current
extend
molecular
method
examin
relationship
upper
airway
virus
bacteria
clinic
andor
radiolog
confirm
pneumonia
outcom
children
major
studi
focus
specif
virus
bacteria
assess
whether
upper
airway
microbiolog
predict
clinic
symptom
none
conduct
popul
similar
pneumonia
risk
central
australian
indigen
children
use
nasopharyng
swab
np
conveni
obtain
lower
airway
specimen
young
children
gener
requir
invas
procedur
eg
bronchoscopi
lung
punctur
howev
np
taken
hospitalis
may
reflect
clinic
symptom
outcom
nasopharyng
np
carriag
popul
high
asymptomat
children
detect
organ
polymeras
chain
reaction
pcr
singl
point
time
necessarili
equat
activ
infect
carriag
np
virus
high
asymptomat
hospitalis
children
central
australian
indigen
children
hospitalis
pneumonia
describ
point
preval
np
bacteria
virus
children
assess
whether
virus
bacteria
detect
np
relat
clinic
definit
pneumonia
tachypnoea
andor
chest
indraw
admiss
durat
sign
given
usual
high
level
np
carriag
bacteria
virus
children
without
pneumonia
target
group
hypothesis
relationship
upper
airway
microb
clinic
symptom
studi
undertaken
april
juli
alic
spring
hospit
northern
territori
australia
sole
hospit
servic
region
alic
spring
hospit
hospit
central
australian
desert
region
serv
popul
approxim
person
dispers
across
kilometr
forti
per
cent
popul
aborigin
resid
remot
commun
time
studi
central
australian
aborigin
children
receiv
haemophilu
influenza
type
b
vaccin
hib
prpomp
conjug
sinc
age
month
june
studi
recruit
pneumococc
conjug
vaccin
introduc
routin
schedul
administ
month
age
booster
dose
pneumococc
polysaccharid
vaccin
month
age
set
children
clinic
suspect
pneumonia
treat
commun
clinic
accord
standard
treatment
protocol
retriev
hospit
occur
oxygen
requir
child
fail
respond
treatment
use
data
collect
prospect
randomis
control
trial
rct
zinc
vitamin
supplement
central
australian
aborigin
children
age
year
hospitalis
pneumonia
children
enrol
trial
ill
cough
tachypnoea
document
fever
pneumonia
diagnos
chest
radiograph
cxr
refer
hospit
blood
cultur
taken
part
clinic
routin
care
hospit
inclus
criteria
rct
ill
tachypnoea
either
document
fever
temperatur
chest
indraw
b
pneumonia
diagnos
cxr
tachypnoea
defin
respiratori
rate
breath
per
minut
age
month
breath
per
minut
age
month
breath
per
minut
age
month
arbitrari
cutoff
breath
per
minut
age
year
exclus
criteria
rct
presenc
bronchiol
syndrom
wheez
coryza
chronic
lung
gastrointestin
neurolog
diseas
inform
consent
obtain
carer
research
nurs
member
research
team
detail
clinic
data
antibiot
prior
admiss
fever
durat
fever
tachypnoea
chest
indraw
demograph
data
gender
birth
weight
age
prior
pneumonia
hospitalis
collect
use
standardis
case
report
form
np
collect
enrol
within
hour
admiss
paediatr
ward
studi
assess
sign
compromis
definit
clinic
pneumonia
tachypneoa
andor
chest
indraw
accessori
muscl
use
assess
chest
indraw
child
respiratori
rate
document
observ
child
second
oxygen
turn
applic
assess
undertaken
train
research
nurs
twice
day
given
known
variabl
children
respiratori
statu
sever
higher
rate
record
daili
basi
total
hour
fever
tachypnoea
total
day
chest
indraw
calcul
episod
hospitalis
pneumonia
includ
rct
exclud
studi
swab
avail
exclud
swab
taken
within
hour
admiss
final
dataset
paper
therefor
compris
episod
np
store
skim
milk
trypton
glucos
glycerol
broth
kept
frozen
analys
previous
demonstr
store
np
valid
viral
bacteri
identif
quantif
cultur
pcr
viral
bacteri
detect
pcr
undertaken
accord
establish
method
laboratori
viru
test
conduct
queensland
paediatr
infecti
diseas
qpid
laboratori
queensland
australia
virus
accord
previous
describ
pcr
method
virus
includ
human
rhinoviru
adenoviru
respiratori
syncyti
viru
rsv
influenza
viru
type
b
parainfluenza
viru
type
human
metapneumoviru
human
coronavirus
human
bocaviru
human
polyomavirus
ki
wu
qpid
laboratori
also
perform
pcr
test
chlamydophila
pneumonia
mycoplasma
pneumonia
quantit
pcr
moraxella
catarrhali
h
influenza
streptococcu
pneumonia
staphylococcu
aureu
perform
menzi
school
health
research
laboratori
darwin
australia
accord
previous
publish
method
primari
studi
approv
central
australian
ethic
committe
queensland
institut
medic
research
approv
number
inform
written
consent
obtain
parentcar
studi
conduct
provis
declar
helsinki
chisquar
test
use
compar
categor
variabl
fever
present
antibiot
prior
admiss
age
categori
presenc
variou
bacteria
virus
multivari
analys
variabl
p
valu
univari
analysi
use
model
provid
adjust
odd
ratio
or
statist
analys
perform
use
stata
version
usa
given
small
number
observ
individu
virus
classifi
virus
two
group
group
rsv
influenza
viru
type
b
human
metapneumoviru
adenoviru
parainfluenza
virus
type
group
b
human
rhinoviru
human
bocaviru
human
polyomavirus
wu
human
coronavirus
group
virus
controversi
primari
reason
classif
base
high
preval
group
b
virus
asymptomat
children
wherea
detect
group
virus
mostli
associ
respiratori
symptom
swab
n
posit
least
organ
tabl
least
bacterium
np
least
viru
human
rhinoviru
polyomavirus
wu
commonli
detect
virus
respect
organ
infrequ
detect
c
pneumonia
n
pneumonia
n
influenza
viru
either
b
n
rsv
n
parainfluenza
viru
type
n
adenoviru
n
bocaviru
n
coronaviru
n
posit
detect
aureu
human
metapneumoviru
parainfluenza
viru
type
coronavirus
tabl
present
relationship
child
characterist
organ
identifi
presenc
tachypnoea
andor
chest
indraw
univari
regress
model
data
shown
covari
significantli
associ
tachypnoea
univari
analys
age
fever
admiss
h
influenza
catarrhali
posit
np
associ
chest
indraw
adjust
analys
age
month
confid
interv
ci
fever
ci
remain
associ
chest
indraw
similarli
age
month
fever
associ
tachypnoea
chest
indraw
combin
analys
adjust
gender
age
prematur
comorbid
gastroenter
fever
presenc
bacteria
andor
viru
type
associ
tachypnoea
andor
chest
indraw
multivari
analys
microbiolog
associ
found
relat
durat
fever
tachypnoea
chest
indraw
tabl
central
australian
indigen
children
hospitalis
pneumonia
high
preval
bacteria
viru
detect
np
multipl
coinfect
common
mycoplasma
chlamydia
rare
found
signific
relationship
np
presenc
type
bacteria
andor
virus
sign
admiss
chest
indraw
tachypnoea
fever
durat
sign
unawar
publish
data
pubm
http
doiorgwwwncbinlmnihgovpubm
search
februari
evalu
relationship
sign
pneumonia
recoveri
children
hospitalis
alri
upper
airway
bacteria
virus
set
high
acut
chronic
respiratori
burden
set
mani
studi
describ
posit
associ
np
microbiolog
alri
symptom
pneumonia
evalu
sign
whodefin
clinic
pneumonia
viral
bacteria
detect
upper
airway
studi
assum
found
upper
airway
aetiolog
caus
pneumonia
other
advoc
microbiolog
eg
pneumococcu
identifi
np
use
diagnos
aetiolog
pneumonia
howev
previous
shown
yield
respiratori
viru
detect
np
aspir
versu
bronchoalveolar
lavag
depend
viru
type
inde
delin
aetiolog
agent
pneumonia
straightforward
direct
lower
airway
specimen
eg
sputum
lung
biopsi
unavail
absenc
posit
blood
cultur
complex
includ
case
definit
use
interpret
cxr
blood
white
cell
count
inflammatori
marker
depth
investig
facil
type
patient
characterist
well
limit
specif
diagnosi
pneumonia
cxr
none
studi
examin
recoveri
sign
clinic
pneumonia
also
like
studi
limit
applic
set
high
infecti
burden
young
age
eg
indigen
australian
remot
commun
lowincom
countri
studi
thu
contribut
medic
literatur
childhood
pneumonia
spite
limit
studi
discuss
neg
find
like
influenc
high
carriag
rate
bacteria
popul
earli
age
result
small
number
children
posit
organ
high
carriag
rate
key
respiratori
bacteria
indigen
australian
children
remot
commun
well
establish
respiratori
bacteria
np
colonis
rate
also
colonis
occur
earli
life
young
week
birth
nasopharynx
indigen
australian
infant
colon
multipl
speci
respiratori
bacteria
catarrhali
h
influenza
pneumonia
rate
per
day
similarli
catarrhali
h
influenza
pneumonia
respiratori
virus
identifi
np
indigen
children
remot
commun
without
acut
otiti
media
without
pneumonia
contrast
find
german
studi
low
baselin
carriag
set
involv
children
alri
describ
bacteria
np
associ
clinic
featur
outcom
among
find
studi
describ
children
aureu
posit
cocolonis
receiv
antibiot
p
receiv
frequent
cxr
p
stay
longer
hospit
p
aureu
singl
colonis
howev
studi
examin
virus
children
pneumonia
remaind
wheez
ill
henc
ill
like
viral
alri
thu
german
studi
incompar
studi
studi
low
preval
rsv
influenza
viru
unexpect
given
children
bronchiol
symptom
eg
wheez
exclud
studi
opportunist
evalu
np
microbiolog
within
rct
henc
associ
compon
find
mani
limit
firstli
sampl
size
rel
small
thu
limit
power
detect
small
differ
group
certainti
examin
interact
could
validli
perform
secondli
control
group
contemporan
evalu
np
carriag
children
hospitalis
pneumonia
higher
hospitalis
reason
howev
studi
aim
evalu
np
microbiolog
symptom
sign
pneumonia
group
children
differ
diseas
thirdli
major
children
remot
commun
clinic
present
time
admiss
ward
would
influenc
treatment
eg
antipyret
oxygen
therapi
prior
antibiot
prior
retriev
hospit
like
children
would
clinic
sign
suggest
pneumonia
present
remot
commun
clinic
howev
scenario
prior
treatment
delay
prior
manag
major
hospit
similar
region
develop
countri
treatment
initi
local
clinic
child
transfer
major
hospit
requir
nevertheless
studi
conduct
commun
level
prior
transfer
hospit
need
highrisk
group
adequ
assess
predictor
symptom
sign
summari
studi
suggest
np
collect
time
hospitalis
like
limit
use
determin
diagnosi
pneumonia
base
key
sign
tachypnoea
chest
indraw
durat
sign
children
high
np
microbi
colonis
rate
larger
cohort
casecontrol
studi
need
confirm
find
